EUROASPIRE V Survey on Cardiovascular Disease Prevention and Diabetes

CompletedOBSERVATIONAL
Enrollment

1,736

Participants

Timeline

Start Date

August 23, 2016

Primary Completion Date

December 28, 2018

Study Completion Date

December 28, 2018

Conditions
Cardiovascular DiseasesCoronary Heart Disease
Interventions
OTHER

There is no intervention

Trial Locations (1)

SW3 6LR

Imperial College London, London

All Listed Sponsors
collaborator

European Society of Cardiology

NETWORK

lead

Imperial College London

OTHER

NCT03511885 - EUROASPIRE V Survey on Cardiovascular Disease Prevention and Diabetes | Biotech Hunter | Biotech Hunter